216 related articles for article (PubMed ID: 7299062)
1. [Immunosuppressive therapy of Behcet's syndrome. Long term follow-up evaluation (author's transl)].
Bonnet M
J Fr Ophtalmol; 1981; 4(6-7):455-64. PubMed ID: 7299062
[TBL] [Abstract][Full Text] [Related]
2. [Immunosuppressive agents and Behçet's syndrome: critical analysis of results].
Bonamour G; Bonnet M
Adv Ophthalmol; 1978; 36():118-29. PubMed ID: 665399
[TBL] [Abstract][Full Text] [Related]
3. Behçet's disease and immunosuppressive treatment. Our personal experience.
Bietti GB; Cerulli L; Pivetti-Pezzi P
Mod Probl Ophthalmol; 1976; 16():314-23. PubMed ID: 55960
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of immunosuppressives in Behçet's syndrome].
Bonnet M
Annee Ther Clin Ophtalmol; 1981; 32():89-111. PubMed ID: 7348139
[No Abstract] [Full Text] [Related]
5. [Value and complications of immunosuppressive therapy in uveitis of Behcet's disease or of other etiology. Apropos of 40 cases].
Niessen F; Campinchi R; Bloch-Michel E
J Fr Ophtalmol; 1982; 5(6-7):407-16. PubMed ID: 7130629
[No Abstract] [Full Text] [Related]
6. [Cytostatic and immunosuppressive treatment of ocular Behçet syndrome].
Schilling H; Bornfeld N; Windeck R; Wessing A; Kirch W
Klin Monbl Augenheilkd; 1990 Feb; 196(2):62-9. PubMed ID: 2325343
[TBL] [Abstract][Full Text] [Related]
7. [Ocular prognosis in Behçet's disease].
Cochereau-Massin I; Wechsler B; Le Hoang P; Le Thi Huong Du; Girard B; Rousselie F; Godeau P
J Fr Ophtalmol; 1992; 15(5):343-7. PubMed ID: 1430813
[TBL] [Abstract][Full Text] [Related]
8. Prognosis in Behcet's disease.
Pivetti Pezzi P; Gasparri V; De Liso P; Catarinelli G
Ann Ophthalmol; 1985 Jan; 17(1):20-5. PubMed ID: 3977213
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
Niccoli L; Nannini C; Benucci M; Chindamo D; Cassarà E; Salvarani C; Cimino L; Gini G; Lenzetti I; Cantini F
Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe Behçet's disease by plasma exchange with or without immunosuppressive drugs. Long term follow-up.
Rifle G; Tanter Y; Mousson C; Besancenot JF; Chalopin JM; Razakarivony H; Deschamps I; Cortet P
Prog Clin Biol Res; 1990; 337():331-5. PubMed ID: 2191327
[No Abstract] [Full Text] [Related]
11. [Behçet's disease. Apropos of 32 cases].
Bitar E; Ghayad E; Ghoussoub K; Sinno W; Chams H; Khoury A; Baloglou P; Kallab K; Halaby C; Chemaly R
Rev Rhum Mal Osteoartic; 1986 Nov; 53(11):621-4. PubMed ID: 3616444
[TBL] [Abstract][Full Text] [Related]
12. [Neuro-Behçet: a follow-up of 4 cases treated with chlorambucil].
Mateos-Colino A; Gonzalez-Gay MA; Cereijo MJ; Santiago J; Rabuñal R; Brañas F
An Med Interna; 1995 Dec; 12(12):600-2. PubMed ID: 8679804
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine in Behçet's disease resistant to conventional therapy.
Caspers-Velu LE; Decaux G; Libert J
Ann Ophthalmol; 1989 Mar; 21(3):111-6, 118. PubMed ID: 2735696
[TBL] [Abstract][Full Text] [Related]
14. Chlorambucil and cyclosporine A in Brazilian patients with Behçet's disease uveitis: a retrospective study.
Zaghetto JM; Yamamoto MM; Souza MB; Silva FT; Hirata CE; Olivalves E; Yamamoto JH
Arq Bras Oftalmol; 2010; 73(1):40-6. PubMed ID: 20464112
[TBL] [Abstract][Full Text] [Related]
15. [Clinical observation of 85 patients with Behçet's uveitis treated with immunosuppressive agents combined with steroids].
Zhao M; Wang H; Jiao X; Wei WB
Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):202-6. PubMed ID: 23866699
[TBL] [Abstract][Full Text] [Related]
16. Behçet's disease.
O'Connor GR
Trans New Orleans Acad Ophthalmol; 1983; 31():199-210. PubMed ID: 6623572
[No Abstract] [Full Text] [Related]
17. Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study.
Houman MH; Naffati H; Khanfir M; Ghannouchi M; Ben Ghorbel I; Lamloum M; El Matri L; Hamzaoui K; Jeddi A; Miled M; Fki M
Tunis Med; 2007 Jun; 85(6):450-3. PubMed ID: 17644895
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy and safety of infliximab in the treatment of Behçet's disease.
Capella MJ; Foster CS
Ocul Immunol Inflamm; 2012 Jun; 20(3):198-202. PubMed ID: 22486265
[TBL] [Abstract][Full Text] [Related]
19. [Eye and Behçet's disease].
Binisti P
Rev Prat; 1999 Nov; 49(18):1999-2003. PubMed ID: 10626485
[TBL] [Abstract][Full Text] [Related]
20. Phacoemulsification cataract extraction and intraocular lens implantation in patients with Behçet's disease.
Berker N; Soykan E; Elgin U; Ozkan SS
Ophthalmic Surg Lasers Imaging; 2004; 35(3):215-8. PubMed ID: 15185789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
